<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
      <PMID Version="1">35606784</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1756-994X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>24</Day>
            </PubDate>
          </JournalIssue>
          <Title>Genome medicine</Title>
          <ISOAbbreviation>Genome Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rapid whole genome sequencing of critically ill pediatric patients from genetically underrepresented populations.</ArticleTitle>
        <Pagination>
          <StartPage>56</StartPage>
          <MedlinePgn>56</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13073-022-01061-7</ELocationID>
        <Abstract>
          <AbstractText>We describe a case series of five infants (age range: 1-90 days; 4 females and 1 male) who presented to Al Jalila Children's intensive care units (ICU) with complex multisystem disorders. Patients were Emirati, Kenyan, Jordanian, Filipino, or Pakistani. Trio rapid whole genome sequencing (rWGS) was performed on all five patients and their parents within the hospital's genomics facility. Results were returned within ~37 h from blood sample draws and were diagnostic in 3 out of 5 patients. Positive findings were a homozygous pathogenic variant in POMT1 gene causing muscular dystrophydystroglycanopathy, a mosaic tetrasomy of the short arm of chromosome 12 (12p13.33p11.1) causing Pallister-Killian syndrome, and compound heterozygous pathogenic variants in the LIPA gene causing lysosomal acid lipase deficiency and Wolman disease. The rWGS analysis provided fast and precise diagnostic findings in those 3 patients and also aided in devising better management plans for them in the intensive care setting. For example, the 3-month-old infant with pathogenic variants in the LIPA gene is now a candidate for an FDA-approved, potentially lifesaving enzyme replacement therapy (sebelipase alfa). Our case series emphasize the feasibility and utility of rWGS in pediatric intensive care setting, in a diverse population that has long been underserved in genomic services. Significant investments in local healthcare infrastructure are needed, globally, for more equitable access of genomic medicine among vulnerable patients.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Halabi</LastName>
            <ForeName>Nour</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramaswamy</LastName>
            <ForeName>Sathishkumar</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El Naofal</LastName>
            <ForeName>Maha</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Taylor</LastName>
            <ForeName>Alan</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yaslam</LastName>
            <ForeName>Sawsan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jain</LastName>
            <ForeName>Ruchi</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alfalasi</LastName>
            <ForeName>Roudha</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shenbagam</LastName>
            <ForeName>Shruti</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bitzan</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Kidney Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yavuz</LastName>
            <ForeName>Lemis</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>General Pediatrics Department, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abulhoul</LastName>
            <ForeName>Hamda</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Metabolic Medicine, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shankar</LastName>
            <ForeName>Shiva</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Critical Care Centre of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janjua</LastName>
            <ForeName>Dalwinder</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Critical Care Centre of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jadhav</LastName>
            <ForeName>Devendrasing</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Critical Care Centre of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al Maazmi</LastName>
            <ForeName>Munira Mahmoud</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Critical Care Centre of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abuhammour</LastName>
            <ForeName>Walid</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Infectious Diseases Department, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alsheikh-Ali</LastName>
            <ForeName>Alawi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Dubai Health Authority, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al Awadhi</LastName>
            <ForeName>Mohamed</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al Khayat</LastName>
            <ForeName>Abdulla</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abou Tayoun</LastName>
            <ForeName>Ahmad N</ForeName>
            <Initials>AN</Initials>
            <Identifier Source="ORCID">0000-0002-9134-1673</Identifier>
            <AffiliationInfo>
              <Affiliation>Al Jalila Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates. Ahmad.Tayoun@ajch.ae.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Genomic Discovery, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates. Ahmad.Tayoun@ajch.ae.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Genome Med</MedlineTA>
        <NlmUniqueID>101475844</NlmUniqueID>
        <ISSNLinking>1756-994X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>23</Hour>
          <Minute>49</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35606784</ArticleId>
        <ArticleId IdType="doi">10.1186/s13073-022-01061-7</ArticleId>
        <ArticleId IdType="pii">10.1186/s13073-022-01061-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gorzynski JE, Goenka SD, Shafin K, Jensen TD, Fisk DG, Grove ME, et al. Ultrarapid Nanopore Genome Sequencing in a Critical Care Setting. N Engl J Med. 2022;386(7):700–2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2112090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Owen MJ, Niemie A-K, Dimmock DP, Speziale M, Nespeca M, Chau KK, et al. Rapid Sequencing-Based Diagnosis of Thiamine Metabolism Dysfunction Syndrome. N Engl J Med. 2021;384(22):2159–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2100365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abou Tayoun AN, Rehm HL. Genetic variation in the Middle East – an opportunity to advance the human genetics field. Genome Med. 2020;12(1):1–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-020-00821-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abou Tayoun AN, Fakhro KA, Alsheikh-Ali A, Alkuraya FS. Genomic Medicine in the Middle East. Genome Med. 2021;13(1):1–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-021-01003-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Illumina Technical note: Variant curation in TruSightTM Software Suite. 2021. https://www.illumina.com/content/dam/illumina/gcs/assembled-assets/marketing-literature/trusight-software-suite-curation-tech-note-m-gl-00051/trusight-software-suite-curation-tech-note-m-gl-000551.pdf . Accessed 20 Jul 2021</Citation>
        </Reference>
        <Reference>
          <Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geis T, Rödl T, Topaloğlu H, Balci-Hayta B, Hinreiner S, Müller-Felber W, et al. Clinical long-time course, novel mutations and genotype-phenotype correlation in a cohort of 27 families with POMT1-related disorders. Orphanet J Rare Dis. 2019;14(1):179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13023-019-1119-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wenger SL, Boone LY, Steele MW. Mosaicism in Pallister i (12p) syndrome. Am J Med Genet. 1990;35(4):523–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320350416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redonnet-Vernhet I, Chatelut M, Salvayre R, Levade T. A novel lysosomal acid lipase gene mutation in a patient with cholesteryl ester storage disease. Hum Mutat. 1998;11(4):335–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9554751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinje T, Wierød L, Leren TP, Strøm TB. Prevalence of cholesteryl ester storage disease among hypercholesterolemic subjects and functional characterization of mutations in the lysosomal acid lipase gene. Mol Genet Metab. 2018;123(2):169–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymgme.2017.11.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pisciotta L, Fresa R, Bellocchio A, Pino E, Guido V, Cantafora A, et al. Cholesteryl ester storage disease (CESD) due to novel mutations in the LIPA gene. Mol Genet Metab. 2009;97:143–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymgme.2009.02.007</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
